Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
563 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07346846 | A Study of BGM-2121 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 35 | BioGate Precision Medicine Corp.INDUSTRY | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07540026 | Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding: A Randomized Controlled Trial | recruiting | N/A | 60 | National Cheng-Kung University HospitalOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT04701476 | TATE and Pembrolizumab (MK3475) in mCRC and NSCLC | recruiting | Phase 2 | 110 | Teclison Ltd.INDUSTRY | 2 | Apr 16, 2026 | clinicaltrials |
| NCT06831669 | Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer | recruiting | — | 250 | Chang Gung Memorial HospitalOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07260344 | Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral Precancer | recruiting | N/A | 400 | Anil ChaturvediNIH | 1 | Apr 14, 2026 | clinicaltrials |
| NCT04686305 | Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC(DL03) | recruiting | Phase 1 | 304 | AstraZenecaINDUSTRY | 19 | Apr 13, 2026 | clinicaltrials |
| NCT05257590 | CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma | recruiting | Phase 2 | 95 | TaiRx, Inc.INDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06143774 | Study of TRX-920 for Patients With Advanced Solid Tumors | recruiting | Phase 1 | 30 | TaiRx, Inc.INDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06487624 | An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors | recruiting | Phase 1 | 50 | FBD Biologics LimitedINDUSTRY | 3 | Apr 13, 2026 | clinicaltrials |
| NCT06754020 | TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis Compared to Healthy Controls | recruiting | N/A | 100 | Yi Ting YehOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07509619 | AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients | recruiting | — | 20 | National Taiwan University HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05048901 | Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors | recruiting | Phase 1 / Phase 2 | 49 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT05927857 | Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . | recruiting | Phase 1 / Phase 2 | 45 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT06064877 | A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma(FIERCE-HN) | recruiting | Phase 3 | 410 | AVEO Pharmaceuticals, Inc.INDUSTRY | 18 | Apr 9, 2026 | clinicaltrials |
| NCT06127446 | The Registry of Genetic Alterations of Taiwan Ovarian Cancer | recruiting | — | 300 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT04849481 | The Research Plan of Taiwan Precision Medicine | recruiting | — | 550 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT06162650 | Total Neoadjuvant Therapy in Rectal Cancer | recruiting | Phase 2 | 42 | National Cheng-Kung University HospitalOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT04906434 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor | recruiting | Phase 1 | 200 | Abbisko Therapeutics Co, LtdINDUSTRY | 3 | Apr 7, 2026 | clinicaltrials |
| NCT06785051 | AI-based Physiotherapy for Oral Cancer Patients | recruiting | N/A | 100 | National Taiwan University HospitalOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT06607627 | PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis | recruiting | Phase 3 | 12 | Alexion Pharmaceuticals, Inc.INDUSTRY | 5 | Apr 1, 2026 | clinicaltrials |
| NCT07033026 | An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. | recruiting | Phase 2 | 136 | NGM Biopharmaceuticals, IncINDUSTRY | 4 | Apr 1, 2026 | clinicaltrials |
| NCT07503496 | Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy | recruiting | N/A | 96 | China Medical University HospitalOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05756322 | The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias | recruiting | Phase 1 / Phase 2 | 90 | Lin BioScience, IncINDUSTRY | 4 | Mar 27, 2026 | clinicaltrials |
| NCT04988555 | A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) | recruiting | Phase 1 / Phase 2 | 606 | Sumitomo Pharma America, Inc.INDUSTRY | 12 | Mar 24, 2026 | clinicaltrials |
| NCT05805631 | Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC | recruiting | Phase 2 | 23 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06111430 | Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer | recruiting | — | 800 | Chang Gung Memorial HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06133062 | Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma(ProtonAB) | recruiting | Phase 2 | 45 | Chang Gung Memorial HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06628674 | Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome. | recruiting | N/A | 110 | Chang Gung Memorial HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07378319 | Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness. | recruiting | N/A | 15 | Taichung Veterans General HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06966778 | Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial | recruiting | N/A | 135 | National Taiwan University HospitalOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07472803 | Longitudinal Body Composition Assessment in Breast Cancer Patients | recruiting | — | 100 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07473687 | Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room(IBPM) | recruiting | — | 315 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07465393 | Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors(exercise) | recruiting | N/A | 66 | Valeria ChiuOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06039644 | To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer | recruiting | N/A | 100 | GenMont Biotech IncorporationINDUSTRY | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07012759 | Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients | recruiting | — | 100 | Fu Jen Catholic UniversityOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT06968871 | Ameliorated Pap Tests and Cervical Cancer Screening Participation | recruiting | N/A | 248 | National Taiwan University HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07064122 | A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) | recruiting | Phase 1 | 72 | AstraZenecaINDUSTRY | 7 | Mar 2, 2026 | clinicaltrials |
| NCT07039162 | Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma | recruiting | Phase 2 | 45 | Ming-Yu LienOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT06678724 | Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip | recruiting | — | 30 | National Taiwan University HospitalOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT05557474 | Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit | recruiting | — | 236 | Chung Shan Medical UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05572944 | Formatting the Risk Prediction Models for Never-Smoking Lung Cancer(FORMOSA) | recruiting | — | 10,000 | Chung Shan Medical UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05875870 | Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer | recruiting | N/A | 200 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06973863 | A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 40 | PharmaEngineINDUSTRY | 2 | Feb 13, 2026 | clinicaltrials |
| NCT06629038 | Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model | recruiting | — | 40 | National Taiwan University HospitalOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07396259 | Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores | recruiting | — | 150 | Chang Gung Memorial HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT07396662 | Endocrine-exocrine Functions and Prognosis After Pancreatectomy | recruiting | — | 3,500 | National Taiwan University HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06127407 | Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen(CHONQUER) | recruiting | Phase 3 | 136 | Servier Bio-Innovation LLCINDUSTRY | 17 | Feb 6, 2026 | clinicaltrials |
| NCT07107490 | A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER | recruiting | Phase 1 | 122 | Chugai PharmaceuticalINDUSTRY | 3 | Feb 6, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials